AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2024
Dec 17, 2024
32559_dirs_2024-12-16_00734f72-f233-4a65-98c1-f3489d9323af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2024-12-12
Reporting Person: Kuriakose Emil (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-12 | Stock Option (Right to Buy) | $6.59 | A | 120000.00 | Acquired | 2034-12-11 | Common Stock (120000.00) | Direct |
Footnotes
F1: 25% of the shares subject to the option vest on the first anniversary measured from December 12, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.